DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kantelhardt EJ, Vetter M, Schmidt M. , et al.
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel.
BMC Cancer 2011;
11: 140
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.